2012 -Welcome to the Nolta Lab at the University Of California, Davis: Health Sciences Campus in Sacramento

Lab focus:

• Human mesenchymal stem cell-mediated repair of damaged tissues: MSCs used to secrete factors for tissue repair and disease correction.  Video showing MSCs in action:  http://vimeo.com/46898303
• Developing therapies for Huntington's disease and vascular disorders in our lab, and other diseases through team science at UC Davis. Great news! CIRM disease team funding was awarded for our HD and Vascular teams! press release:

  http://www.ucdmc.ucdavis.edu/publish/news/newsroom/6808/?mode=draft

• Facilitating teamwork and performing IND-enabling studies to enable clinical trials of stem cell therapy. We currently have 7 adult (non-hematopoietic) stem cell clinical trials ongoing at UCD, and 16 in the pipeline.  http://www.ucdavisstemcell.org/cgi-bin/page.asp?sid=2&hid=13&id=480

CIRM announces funding for disease team therapy research grants, 3 of the four top scores in the state belonging to UC Davis!

CIRM press release:

http://cirm.ca.gov/PressRelease_2012-07-26

Listen to KQED Forum Interview with Jan Nolta and Alan Trounson - July 27, 2012 (60 minutes)

Our laboratory works in translational biology at the GLP, or “good laboratory practice” level, required to take stem cell therapies, gene therapy and tissue repair studies from the bench to the bedside.

Dr. Nolta is Director of the UC Davis Stem Cell Program and Scientific Director of the GMP facility and assists other Principal Investigators with the rules and regulations involved with obtaining approvals from the Recombinant advisory committee (RAC) and the FDA for cellular therapies. She works closely with Dr. Gerhard Bauer, the Director of the Good Manufacturing Practice Facility in the UC Davis Institute for Regenerative Cures.

Basic/translational work in our lab centers around developing stem cell therapies for peripheral vascular disease and other ischemic disorders, and using stem cells to treat neurodegenerative disorders, primarily focusing on Huntington's Disease.